EE200100052A - Oksüdeerumisvastane, vohamisvastane kompositsioon, mis sisaldab karnitiini ning karotenoidi - Google Patents

Oksüdeerumisvastane, vohamisvastane kompositsioon, mis sisaldab karnitiini ning karotenoidi

Info

Publication number: EE200100052A
Authority: EE; Estonia
Prior art keywords: carotenoid; antioxidant; composition containing; containing carnitine; antiproliferative composition
Prior art date: 1998-08-03

Application number

EEP200100052A

Other languages

English (en)

Inventor

Cavazza Claudio

Original Assignee

Sigma-Tau Healthscience S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-03

Filing date

1999-07-29

Publication date

2002-06-17

1999-07-29 Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.

2002-06-17 Publication of EE200100052A publication Critical patent/EE200100052A/et

Links

PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title 1
230000001028 anti-proliverative effect Effects 0.000 title 1
239000003963 antioxidant agent Substances 0.000 title 1
230000003078 antioxidant effect Effects 0.000 title 1
229960004203 carnitine Drugs 0.000 title 1
235000021466 carotenoid Nutrition 0.000 title 1
150000001747 carotenoids Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Natural Medicines & Medicinal Plants (AREA)
Toxicology (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Biochemistry (AREA)
Botany (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Ophthalmology & Optometry (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Dermatology (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EEP200100052A 1998-08-03 1999-07-29 Oksüdeerumisvastane, vohamisvastane kompositsioon, mis sisaldab karnitiini ning karotenoidi EE200100052A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT1998RM000516A IT1302125B1 (it)	1998-08-03	1998-08-03	Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide
PCT/IT1999/000251 WO2000007581A2 (en)	1998-08-03	1999-07-29	Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid

Publications (1)

Publication Number	Publication Date
EE200100052A true EE200100052A (et)	2002-06-17

Family

ID=11406082

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100052A EE200100052A (et)	1998-08-03	1999-07-29	Oksüdeerumisvastane, vohamisvastane kompositsioon, mis sisaldab karnitiini ning karotenoidi

Country Status (21)

Country	Link
EP (1)	EP1102584A2 (et)
JP (1)	JP2002522382A (et)
KR (1)	KR20010072146A (et)
CN (1)	CN1311674A (et)
AR (1)	AR021172A1 (et)
AU (1)	AU5064199A (et)
BR (1)	BR9912703A (et)
CA (1)	CA2338035A1 (et)
EE (1)	EE200100052A (et)
HK (1)	HK1039062A1 (et)
HU (1)	HUP0102807A2 (et)
IL (1)	IL140797A0 (et)
IS (1)	IS5816A (et)
IT (1)	IT1302125B1 (et)
MA (1)	MA26666A1 (et)
NO (1)	NO20010532L (et)
PL (1)	PL346161A1 (et)
SK (1)	SK1252001A3 (et)
TN (1)	TNSN99152A1 (et)
TR (1)	TR200100333T2 (et)
WO (1)	WO2000007581A2 (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1286704T3 (da)	2000-06-02	2014-09-22	Univ Texas	Ethylendicystein (EC)-glucose analoge konjugater
US6923960B2 (en)	2001-10-03	2005-08-02	Vsl Pharmaceuticals Inc.	Antioxidant combination composition and use thereof
KR100523562B1 (ko)	2001-10-29	2005-10-25	한국과학기술연구원	손바닥선인장 추출물 및 이로부터 분리된 화합물을함유하는 신경세포 보호용 조성물
JP4527938B2 (ja) *	2002-07-23	2010-08-18	オルビス株式会社	抗酸化用の経口投与組成物
JP4334189B2 (ja) *	2002-07-30	2009-09-30	カゴメ株式会社	Ａｇｅ生成阻害剤
ITRM20020620A1 (it) *	2002-12-13	2004-06-14	Sigma Tau Ind Farmaceuti	Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
JP4369924B2 (ja)	2003-04-14	2009-11-25	日本曹達株式会社	ジアミン誘導体、製造法及び抗酸化薬
US9050378B2 (en)	2003-12-10	2015-06-09	Board Of Regents, The University Of Texas System	N2S2 chelate-targeting ligand conjugates
EP1711070B1 (en) *	2004-01-28	2015-12-09	Nestec S.A.	Nutritional composiition for improving skin condition and preventing skin diseases
US8758723B2 (en)	2006-04-19	2014-06-24	The Board Of Regents Of The University Of Texas System	Compositions and methods for cellular imaging and therapy
US10925977B2 (en)	2006-10-05	2021-02-23	Ceil>Point, LLC	Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
RU2619342C1 (ru) *	2016-02-24	2017-05-15	федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет"	Препарат для профилактики и лечения свободнорадикальной патологии у животных
CN113491687A (zh) *	2020-04-02	2021-10-12	常州高新技术产业开发区三维工业技术研究所有限公司	一种解毒药物组合物及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU518617B2 (en) *	1977-04-29	1981-10-08	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Therapeutic application of acetyl-d, 1-carnitine
EP0400547A1 (en) *	1989-06-02	1990-12-05	Abbott Laboratories	Parenteral nutrition product
IT1276225B1 (it) *	1995-10-17	1997-10-27	Sigma Tau Ind Farmaceuti	Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1277953B1 (it) *	1995-12-21	1997-11-12	Sigma Tau Ind Farmaceuti	Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283967B1 (it) *	1996-03-29	1998-05-07	Sigma Tau Ind Farmaceuti	Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US5667791A (en) *	1996-05-31	1997-09-16	Thione International, Inc.	X-ray induced skin damage protective composition
US5895652A (en) *	1996-07-29	1999-04-20	Longevity Institute International	Method of metabolic adjuvanation and cellular repair
CA2280093A1 (en) *	1997-02-04	1998-08-06	John V. Kosbab	Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (it) *	1997-03-20	1998-12-29	Sigma Tau Ind Farmaceuti	Composizione nutritiva terapeutica per soggetti affetti da diabete mellito

1998
- 1998-08-03 IT IT1998RM000516A patent/IT1302125B1/it active IP Right Grant
1999
- 1999-07-29 TR TR2001/00333T patent/TR200100333T2/xx unknown
- 1999-07-29 BR BR9912703-2A patent/BR9912703A/pt not_active Application Discontinuation
- 1999-07-29 EP EP99935044A patent/EP1102584A2/en not_active Withdrawn
- 1999-07-29 CN CN99809268A patent/CN1311674A/zh active Pending
- 1999-07-29 EE EEP200100052A patent/EE200100052A/et unknown
- 1999-07-29 KR KR1020017001339A patent/KR20010072146A/ko not_active Withdrawn
- 1999-07-29 SK SK125-2001A patent/SK1252001A3/sk unknown
- 1999-07-29 HU HU0102807A patent/HUP0102807A2/hu unknown
- 1999-07-29 AU AU50641/99A patent/AU5064199A/en not_active Abandoned
- 1999-07-29 CA CA002338035A patent/CA2338035A1/en not_active Abandoned
- 1999-07-29 WO PCT/IT1999/000251 patent/WO2000007581A2/en not_active Ceased
- 1999-07-29 PL PL99346161A patent/PL346161A1/xx unknown
- 1999-07-29 HK HK02100334.3A patent/HK1039062A1/zh unknown
- 1999-07-29 IL IL14079799A patent/IL140797A0/xx unknown
- 1999-07-29 JP JP2000563266A patent/JP2002522382A/ja active Pending
- 1999-07-30 TN TNTNSN99152A patent/TNSN99152A1/fr unknown
- 1999-08-03 MA MA25710A patent/MA26666A1/fr unknown
- 1999-08-03 AR ARP990103863A patent/AR021172A1/es unknown
2001
- 2001-01-16 IS IS5816A patent/IS5816A/is unknown
- 2001-01-31 NO NO20010532A patent/NO20010532L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20010532D0 (no)	2001-01-31
KR20010072146A (ko)	2001-07-31
IT1302125B1 (it)	2000-07-31
CA2338035A1 (en)	2000-02-17
MA26666A1 (fr)	2004-12-20
JP2002522382A (ja)	2002-07-23
IS5816A (is)	2001-01-16
WO2000007581A2 (en)	2000-02-17
PL346161A1 (en)	2002-01-28
AU5064199A (en)	2000-02-28
ITRM980516A0 (it)	1998-08-03
BR9912703A (pt)	2001-05-02
EP1102584A2 (en)	2001-05-30
ITRM980516A1 (it)	2000-02-03
CN1311674A (zh)	2001-09-05
HUP0102807A2 (hu)	2002-03-28
HK1039062A1 (zh)	2002-04-12
TNSN99152A1 (fr)	2005-11-10
IL140797A0 (en)	2002-02-10
AR021172A1 (es)	2002-07-03
TR200100333T2 (tr)	2001-07-23
WO2000007581A3 (en)	2000-05-11
NO20010532L (no)	2001-03-20
SK1252001A3 (en)	2001-08-06

Publication	Publication Date	Title
IT1308659B1 (it)	2002-01-09	Reticolante per fotoresist e composizione fotoresist comprendente lostesso.
DE69934884D1 (de)	2007-03-08	Polyethylene glycol-polyorthoester, polyethylene glycol-polyorthoester-polyethylene glycol, und polyorthoester-polyethylene glycol-polyorthoester blockcopolymere
EE200100113A (et)	2002-06-17	Atsetüül-L-karnitiini ning alfa-lipohapet sisaldav oksüdeerumisvastane kompositsioon
DE69924176D1 (de)	2005-04-21	Gemeinsamer Maximalwahrscheinlichkeits-Folgeschätzer mit dynamischer Kanalsbeschreibung
DE69736354D1 (de)	2006-08-31	Anthrapyridonverbindungen, wässrige tintenzusammensetzung und die damit gefärbten gegenstände
DE69708120D1 (de)	2001-12-13	Laser-absorbierende, lichtbleichbare zusammensetzungen
DE69521082D1 (de)	2001-07-05	Metallisches bakterizides Mittel
DE69900817D1 (de)	2002-03-14	Verbindungsstreifen, verbindungsverfahren und einheit, die diesen verbindungs-streifen beinhaltet
MXPA03004366A (es)	2003-08-19	Composicion cosmetica suave con retinoides estabilizados.
GB9817235D0 (en)	1998-10-07	Compound,composition and use
NO20010873D0 (no)	2001-02-21	Mikropartikkel-blanding
IT1308660B1 (it)	2002-01-09	Reticolante per fotoresist e composizione fotoresist comprendente lostesso.
GB9817236D0 (en)	1998-10-07	Compound,composition and use
NO20010532D0 (no)	2001-01-31	Antioksidativ, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid
BR9903981B1 (pt)	2010-08-24	compostos e composiÇÕes de fragrancia de metilciclotetradec-5-en-1-onas.
TR199700147A2 (tr)	1997-09-21	Mikrop öldürücü terkip.
GB9817238D0 (en)	1998-10-07	Compound,composition and use
BR9503900A (pt)	1996-09-17	Composição polimérica útil como um antioxidante
ZA995878B (en)	2000-03-31	High voltage transformer.
DE69908213D1 (de)	2003-07-03	Verkorkungsmaschine
ID26368A (id)	2000-12-14	Turunan-turunan 2 deoksi higromisin
DE59909590D1 (de)	2004-07-01	Azidfreie, gaserzeugende zusammensetzung
FR2716218B1 (fr)	1996-06-07	Caniveau de haute résistance intégré.
DE69908923D1 (de)	2003-07-24	1,3,4-thiadiazolylazofarbstoffe-enthaltende tintenzusammensetzungen
SE9403509D0 (sv)	1994-10-13	Antioxidant composition